Tim Uden, Author at European Medical Journal - Page 12 of 28

Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…

A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study

Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…

Home Healthcare Providers in Type 1 Diabetes

HCL systems have the potential to improve glycaemic control in people living with T1D.1-4 HCLs combine continuous glucose monitoring…

Hidden Obesity Complication

Since the release of the EMPA-REG trial, in which for the first time an antihyperglycaemic agent demonstrated a reduction…

Platelet Volume and Glycaemic Control Correlation

Diabetes is emerging as an epidemic worldwide and is a global public health problem. The International Diabetes Federation (IDF)…

Preconception Care in Diabetes

According to the World Health Organization (WHO), the number of people with diabetes has quadrupled since the 1980s, with estimates…

The Unmet Need for Patients with Vitiligo is High

Infographic on ‘The Unmet Need for Patients with Vitiligo is High.’ This infographic is funded and co-developed by AbbVie…

Learn to SHARE the decision for dialysis modality selection

In this interactive case study, healthcare professionals have the opportunity to learn more about the SHARE approach for shared…

Breathing New Life Into Acute Respiratory Care: Proactively Improving Long-Term Outcomes

Approximately 262 million people have asthma globally, with around 1,000 asthma-related deaths every day. In Europe alone…

Exploring Type 2 Inflammation in Chronic Obstructive Pulmonary Disease

Rabe began the presentation by highlighting two hypothetical patients with different ages, physiologies, and backgrounds to contextualise…